Do you have the passion to join a group whose mission is to pioneer the discovery of a new class of medicines to treat diseases unaddressed by today’s therapies? Does it excite you to be a part of a company with a focus on cancer and genetically validated targets in other disease areas with unmet medical need? If yes, you may be a great fit to join Arrakis on our path to bring powerful new therapies to millions of patients.
Your Impact at Arrakis
The mission of Arrakis Therapeutics is to extend small molecule drug discovery into new realms of biology by discovering and developing compounds that selectively target RNA. By targeting specific RNA structure/function relationships, Arrakis will generate drug candidates with novel mechanisms of action for high-value molecular targets that are challenging to address via more traditional protein-centric approaches. Our efforts span a wide range of disease areas including oncology, neuroscience and rare disease, with a focus on indications with high unmet medical need.
Arrakis is seeking a computational chemist to join our rapidly growing company in pursuit of targeting RNA with small molecules. The successful candidate will support all aspects of medicinal chemistry programs from hit to lead and beyond, participate in computational informatics strategies, interface with consultants and collaborate across disciplines within Arrakis. The ideal candidate will enjoy working in a collaborative, fast-paced start-up environment, leveraging a high degree of integrity, intelligence and innovation to make a large impact on our mission.
Interested in learning more about Arrakis? Click on the links below!
Arrakis is an Equal Opportunity/Affirmative Action Employer. All qualified applicants will receive equal consideration for employment without regard to race, color, religion, national origin or ancestry, sex, pregnancy, sexual orientation, gender identity, age, disability, military service, veteran status, genetic information, or any other characteristic protected by law.
Your application was submitted successfully.